ABTA President and CEO Ralph DeVitto is retiring February 2025, after serving the ABTA for seven years. His legacy highlights remarkable achievements, including significantly increasing the organization’s revenue resulting in a substantial boost in research funding and patient resources dedicated to combating brain tumors. Ralph strengthened the ABTA’s mission and broadened its reach to support countless patients, caregivers, families, researchers and stakeholders in the brain tumor community.
We share our deepest gratitude to Ralph for his transformative leadership, integrity, and unwavering commitment in the fight against brain tumors.
Watch his impact through the years!
